2309 Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer. (September 2015) - Schoennemann, K.R.; Vestermark, L.W.; Jensen A, H.; Bjerregaard K, J.; Krogh, M.; Qvortrup, C.; Tarpgaard S, L.; Ejlsmark, M.W.; Pfeiffer, P.